Antitumor effects of TNF-beta, 5-FU and their combinations on cervical carcinoma cell lines

Cervical carcinoma is one type of cancer with a high mortality rate in females. In this study, we investigated the cytotoxic effects of TNF-beta, 5-FU and their combinations on human cervical carcinoma cell lines, ME180 and HeLa. The highest degree of cytotoxic effect was obtained with 5-FU on both cell lines. While high concentrations of TNF-beta showed cytotoxic effects on both cell lines, the lowest dose induced growth. Combination treatment of 5-FU and TNF-beta gave a slightly higher cytotoxic and antiproliferative response compared to individual use of 5-FU and TNF-beta on both cell lines.

PDF

___

1. Old LS. Tumor necrosis factor (TNF). Science, 8; 230 (4726): 630-2, 1985.
2. Kunkel SL, Remick DG, Strieter RM, Larrick JW. Mechanism that regulate the production and effects of tumor necrosis factor-alpha. Cri Rev Immunol. 9 (2): 93-117, 1989.
3. Fisher W. Tumor necrosis factor. Febs, 285 (2): 199-212, 1991.
4. Machester KM, Heston WDW and Donner DB Tumor necrosis factor induced cytotoxicity is accompanied by intracellular mitogenic signals in ME180 human cervical carcinoma cells. Biochem J, 290, 185-190, 1993.
5. Lomeo AM, Avolio C, Iacobellis G, Manzione L. 5-Fluorouracil cardiotoxicity. Eur J Gynnaecol Oncl. 11 (3): 237-241, 1990.
6. Yarden A, Kimchi A. Tumor necrosis factor reduces c-myc expression and cooperates with IFN gamma in HeLa cells. Science, Dec 12; 234 (4782): 1419-21. 1986.
7. Nguyen HN, Nordqvist SR. Chemotherapy of advenced and recurrent cervical carcinoma. Seminars in Surgical Oncology. 16 (3): 247-250., 1999.
8. Ueda M, Kitaura K, Kusada O, Mochizuki Y, Yamada N, Terai Y, Kumagai K, Ueki K , Eeki M. Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequnt effects on 5- fluorouracil sensitivity in tumor cells. Japanese Journal Of Cancer Research. 91 (11) 1185-1191, 2000.
9. Wadler S, Haynes H, Beitler JJ, Hu X, Fells S, Camacho M, Levine B and Wiernik PH. Phase II clinical trial with 5- fluouracil, recombinant interferon-a-2b, and cisplatin for patients with metastatic or regionally advenced carcinoma of esophagus. Cancer, 78 (1): 30-34, 1996.
10. Sugumachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M and Akiyoshi T. Postoperative combing 5-fluorouracil infusion and 1-hexylcarbamoyl-5- fluorocil admisnistration after curative resection. Cancer, 77 (1): 36-43, 1996.
11. MarshWR, Chu MN, Mendenhall MW, Lauwers YG, Bewsher C, Copeland ME. Properative treatmend of patient with locally advenced unresectable rectal adenocarcinoma utilizing continuous chronobioloically shaped 5-fluorouracil infusion and radiation therapy. Cancer, 78 (78): 217-225, 1996.
12. Gebbia V, Majello A, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fontunato S, Colucci G and Gebbia N.Cancer, 78 (6): 1300-1307, 1996.
13. Reiter Z, Ozes ON, Blatt LM and Taylor MW. A dual anti-tumor effect of a combination of IFN-alpha or IL-2 and 5- FU on natural killer cell-mediated cytotoxicity. Clinical Immunology and Immunopathology, 62 (1): 103-111, 1992.
14. Schiller JH, Bittner G. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines. Int J Cancer, Jul
15; 46 (1): 61-6, 1990. 15. Zhao E, Zhou M, Fu C, Shen B, Zhang Q, Lian L. Effects of TNF alone or in combination with chemotherapeutic agents on human ovarian cancers in vitro and in nude mice. Chin Med J, Aug; 108 (8): 571-5, 1995.
16. Oka Y, Naomoto Y, Yasuoka Y, Hatano H, Haisa M, Tanaka N, Orita K. Apoptosis in cultured human colon cancer cells induced by combined treatments with 5-fluorouracil, tumor necrosis factor-alpha and interferonalpha. Jpn J Clin Oncol, 27 (4): 231-5, 1997.
17. Li Y, Ito S, Cheng W, Ishii Y. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines. Anticancer Res, 16 (4A): 1771-4, 1996.
18. Muc M, Baranowski M, Braczkowski R. Treament of advanced pancreatic cancer with IFN-alpha, TNF and 5-FU. Wiad Lek, 48 (12): 198-202, 1995.
19. Aota K, Azuma M, Yamashita T, Tamatani T, Motegi K, Ishimaru N, Hayashi Y, Sato M. 5-Fluorouracil induces apoptosis through the suppression of NF-kappaB activity in human salivary gland cancer cells. Biochem Biophys Res Commun, 14; 273 (3): 1168-74, 2000.
20. Tanaka N, Kojima K, Muro M, Naomoto Y, Moreira LF, Orita K. Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5- fluorouracil on a human tumor xenograft. Anticancer Res, 15 (5B): 1949-52, 1995.
21. Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res,1; 61 (3): 1029-37, 2001.
22. Asaga T, Inaba M, Nagano A, Yanoma S. Induction of apoptosis in breast cancer cells by preoperative oral administration of 5-fluorouracil. Gan To Kagaku Ryoho, 28 (1): 49-53, 2001.